metabolicMolecular Weight: 59669

Dulaglutide

Trulicity

A once-weekly GLP-1 receptor agonist approved for type 2 diabetes treatment. Provides sustained glucose control with convenient weekly dosing.

Mechanism

Long-acting GLP-1 receptor agonist providing sustained glucose control and weight management with once-weekly dosing.

Half-Life

5 days

Administration

Subcutaneous

Technical Protocol

Dulaglutide: Comprehensive Research Guide

Overview

Dulaglutide (Trulicity) is a long-acting GLP-1 receptor agonist designed for once-weekly administration. Its extended half-life of approximately 5 days provides sustained glucose control and makes it one of the most convenient diabetes medications available.

Mechanism of Action

  • GLP-1 Receptor Agonism: Activates GLP-1 receptors throughout the body
  • Insulin Secretion: Enhances glucose-dependent insulin release
  • Glucagon Suppression: Reduces glucagon secretion
  • Gastric Emptying: Delays gastric emptying
  • Appetite: Promotes satiety and reduces food intake

Research Applications

Type 2 Diabetes

  • Glycemic Control: Significant HbA1c reduction
  • Cardiovascular Benefits: Reduces major adverse cardiovascular events
  • Weight Management: Promotes weight loss
  • Convenience: Once-weekly dosing improves adherence

Dosage

  • Starting: 0.75 mg once weekly
  • Maintenance: 1.5 mg once weekly
  • Maximum: 4.5 mg once weekly
  • Administration: Subcutaneous injection, any day of week

Side Effects

  • GI Effects: Nausea, diarrhea, vomiting
  • Hypoglycemia: Low risk when used alone
  • Pancreatitis: Rare but serious

This information is for research and educational purposes only. Dulaglutide is a prescription medication.

Peer-Reviewed Citations

Dulaglutide and cardiovascular outcomes in type 2 diabetes

Gerstein HC, et al. • Lancet (2019)

Access Research

Frequently Asked Questions

What is Dulaglutide?

A once-weekly GLP-1 receptor agonist approved for type 2 diabetes treatment. Provides sustained glucose control with convenient weekly dosing.

How does Dulaglutide work?

Long-acting GLP-1 receptor agonist providing sustained glucose control and weight management with once-weekly dosing.

What is the typical dosage of Dulaglutide in research?

The typical research dosage of Dulaglutide is 1.5-4.5 mg (range: 0.75-4.5 mg). Common administration routes include Subcutaneous.

How should Dulaglutide be stored?

Store at 2-8°C, do not freeze

Related Metabolic Peptides